Coagulation studies
Last updated: Wednesday, 05, December, 2007
MBS Online Search Page: Click here for details
| Item | Process |
|---|---|
| Specimen | 4.5 mL blood added to 0.5 mL citrate + 5 mL of EDTA anticoagulated blood. |
| Method | See Activated partial thromboplastin time and Prothrombin time. Other coagulation screening tests could include Thrombin time, Fibrinogen, and D-Dimer test. |
| Application | Routinely a full blood count (FBC) is included to assess the adequacy of the platelet count. The combination of an APTT and a PT as 'screening tests' may not detect clinically significant bleeding disorders; the sensitivity of a detailed clinical assessment is high. In the pre-operative assessment of patients, these tests should not be routinely performed. However, in a patient with a history of abnormal bruising or bleeding, these tests alone may well be inadequate. A simple pre-operative screening questionairre could include questions concerning:
If the screening history is negative, then:
If the screening history is positive or if the surgery is likely to impair haemostasis e.g. cardiac surgery, then a coagulation screen is recommended. Additional testing may be indicated if the history is suspicious for a bleeding diatheses even though the initial screening tests are negative, von Willebrand's disease being the most common cause. |
| Interpretation | Normal results do not exclude a clinically significant bleeding disorder. False positive results are common. See individual tests for interpretation of validated abnormal results. |
| Reference | Eisenberg JM et al. Arch Surg 1982; 117: 48-51. McPherson J and Street A. Aust Prescriber 1995; 18: 38-41. Favoloro EJ. Aust J Med Sci 1994; 15: 39-45. |
